Antinuclear antibodies. Clinical significance of titers and fluorescence patterns.
D000974:Antibodies, Antinuclear / Q000032:analysis*; D001168:Arthritis / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001796:Blood Protein Disorders / Q000276:immunology; D003095:Collagen Diseases / Q000097:blood / Q000276:immunology*; D003872:Dermatitis / Q000276:immunology; D003920:Diabetes Mellitus / Q000276:immunology; D005234:Fatty Liver / Q000276:immunology; D005258:Felty Syndrome / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006073:Gout / Q000276:immunology; D006505:Hepatitis / Q000276:immunology; D006801:Humans; D006973:Hypertension / Q000276:immunology; D008171:Lung Diseases / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D001523:Mental Disorders / Q000276:immunology; D009157:Myasthenia Gravis / Q000276:immunology; D010019:Osteomyelitis / Q000276:immunology; D011000:Pleurodynia, Epidemic / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology; D005719:gamma-Globulins
D000974:Antibodies, Antinuclear; D005719:gamma-Globulins